Search

Your search keyword '"Alya Heirali"' showing total 21 results

Search Constraints

Start Over You searched for: Author "Alya Heirali" Remove constraint Author: "Alya Heirali"
21 results on '"Alya Heirali"'

Search Results

1. Core socioDemographic data variables in ICU Trials (CoDe-IT): a protocol for generating core data variables using a Delphi consensus process

2. Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)

3. Cystic Fibrosis Patients Infected With Epidemic Pseudomonas aeruginosa Strains Have Unique Microbial Communities

4. Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections.

5. Principles and Terminology for Host–Microbiome–Drug Interactions

6. Sputum microbiota in adults with CF associates with response to inhaled tobramycin

7. Bugs as drugs: The role of microbiome in cancer focusing on immunotherapeutics

8. Spotting Potential Opportunities for Teachable moments (SPOT)

9. Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis

10. 989P Autoimmune panels as predictors of immune-related adverse events (irAEs) in patients (pts) treated with immune checkpoint inhibitors (ALERT)

11. The effects of inhaled aztreonam on the cystic fibrosis lung microbiome

12. Cystic Fibrosis Patients Infected With Epidemic

13. Mega- and meta-analyses of fecal metagenomic studies in predicting response to immune checkpoint inhibitors

14. Prospective manipulation of the gut microbiome with Microbial Ecosystem Therapeutic 4 (MET4) in locoregionally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation (ROMA2)

15. Muslim perspectives on advance care planning: a model for community engagement

16. First-in-class microbial ecosystem therapeutics 4 (MET4) in metastatic solid cancer patients treated with immunotherapy: MET4-IO

17. A longitudinal characterization of the Non-Cystic Fibrosis Bronchiectasis airway microbiome

18. The effects of cycled inhaled aztreonam on the cystic fibrosis (CF) lung microbiome

19. Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis

20. Effect of freezing sputum on Pseudomonas aeruginosa population heterogeneity

21. Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections

Catalog

Books, media, physical & digital resources